Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT
Revolution Medicines Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -812.06M | -697.51M | -600.09M | -567.06M | -519.21M | -484.27M | -436.37M | -331.34M | -296.23M | -259.16M | -248.71M | -244.87M | -224.49M | -207.56M | -187.09M | -168.62M | -142.9M | -125.82M |
Depreciation & Amortization | -13.57M | 9.97M | 9.01M | 8.48M | 10.56M | 9.54M | 9.31M | 9.05M | 9.34M | 9.9M | 9.66M | 9.12M | 8.44M | 7.94M | 7.33M | 6.97M | 6.85M | 6.68M |
Stock-Based Compensation | 97.13M | 88.07M | 79.2M | 82.19M | 75.08M | 68.28M | 61.77M | 44.66M | 39.13M | 34.25M | 31.2M | 29.08M | 26.77M | 23.98M | 20.72M | 17.16M | 14M | 10.71M |
Other Working Capital | 28.57M | 38.62M | 8.4M | 4.53M | -15.25M | -16.02M | 907K | -20.24M | -15.09M | -17.42M | -22.01M | -13.05M | -7.96M | -6.34M | -1.66M | -180K | -7.7M | -4.25M |
Other Non-Cash Items | -11.54M | -44.69M | 693K | 3.79M | 10.62M | 18.53M | -18.17M | -11.88M | 63K | 4.94M | 9.18M | 12.26M | 2.6M | 3.26M | 3.13M | 2.45M | 1.85M | 1.25M |
Deferred Income Tax | -762K | -762K | -762K | -43K | -3.91M | -3.91M | -3.91M | -4.29M | -419K | -419K | -419K | n/a | n/a | n/a | n/a | 359K | 359K | 359K |
Change in Working Capital | 55.15M | 52.84M | 3.19M | -17.63M | -33.48M | -7.47M | 36.8M | 1.99M | 16.9M | -9.32M | -13.49M | 4.36M | -45K | 7.28M | 8.72M | 8.73M | -3.55M | -2.47M |
Operating Cash Flow | -684.9M | -591.31M | -557.44M | -539.71M | -509.79M | -448.74M | -350.57M | -291.8M | -243.04M | -231.63M | -224.4M | -201.88M | -186.73M | -165.09M | -147.18M | -132.95M | -123.38M | -109.29M |
Capital Expenditures | -15.46M | -10.41M | -10.31M | -11.4M | -10.42M | -9.14M | -7.73M | -8.29M | -9.28M | -10.69M | -10.82M | -9.12M | -6.05M | -4.84M | -6.53M | -6.51M | -6.75M | -5.91M |
Cash Acquisitions | n/a | n/a | n/a | 884.05M | 804.16M | 846.59M | 840.83M | -38.99M | 40.9M | -66.45M | -60.7M | -64.93M | -64.93M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.1B | -1.94B | -2.14B | -1.96B | -1.77B | -1.57B | -1.06B | -699.65M | -742.57M | -694.05M | -612.77M | -563.25M | -518.53M | -669.12M | -671.34M | -605.4M | -631.2M | -558.13M |
Sales Maturities Of Investments | 1.72B | 1.63B | 1.59B | 1.43B | 1.33B | 982.08M | 724.05M | 738.63M | 581.76M | 640.59M | 599.47M | 563.89M | 609.37M | 573.55M | 535.75M | 524.21M | 479.45M | 391.83M |
Other Investing Acitivies | n/a | 110.34M | -134.46M | -1.02B | -938.62M | -1.09B | -840.83M | 38.99M | -160.81M | -53.46M | -13.3M | 644K | 90.83M | -95.56M | -135.59M | -81.19M | -151.75M | -166.3M |
Investing Cash Flow | -396.05M | -322.38M | -554.39M | -541.89M | -443.07M | -594.56M | -342.6M | 30.7M | -170.09M | -64.14M | -24.12M | -8.48M | 84.78M | -100.4M | -142.12M | -87.7M | -158.49M | -172.21M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 6.51M | 5.03M | 5.03M | 6.48M | 6.48M | 3.32M | 3.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 354.74M | 113.13M | 113.06M | 850.67M | 848.68M | 843.75M | 843.44M | 5.53M | 4.73M | 3.58M | 3.39M | 2.58M | 2.69M | 2.12M | 2.37M | 3.23M | 3.98M | 3.2M |
Financial Cash Flow | 1.21B | 959.48M | 959.41M | 924.96M | 848.68M | 905.8M | 1.23B | 441.21M | 688.53M | 625.33M | 301.43M | 260.8M | 12.78M | 12.22M | 294.18M | 284.94M | 453.5M | 451.3M |
Net Cash Flow | 127.61M | 45.79M | -152.42M | -157.28M | -104.82M | -138.14M | 535.39M | 180.11M | 275.41M | 329.56M | 52.91M | 50.44M | -89.17M | -253.28M | 4.88M | 64.28M | 171.62M | 169.8M |
Free Cash Flow | -700.36M | -601.72M | -567.74M | -551.11M | -520.21M | -457.88M | -358.3M | -300.08M | -252.31M | -242.32M | -235.22M | -211M | -192.78M | -169.93M | -153.71M | -139.46M | -130.13M | -115.2M |